These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10827525)

  • 1. [Sale of oral contraceptives, births and abortions prior to and after the "Marvelon issue"].
    Skjeldestad FE
    Tidsskr Nor Laegeforen; 2000 Jan; 120(3):339-44. PubMed ID: 10827525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives.
    Skjeldestad FE
    Contraception; 1997 Jan; 55(1):11-4. PubMed ID: 9013055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Negative reports on oral contraceptives--increased number of interrupted pregnancies].
    Nilsen ST; Iversen OE
    Tidsskr Nor Laegeforen; 1996 Nov; 116(29):3486-8. PubMed ID: 9019855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alarming increase in the number of abortions. Does fear of thrombosis limit the use of oral contraceptives?].
    Milsom I; Odlind V; Hedberg C; Lidegaard O
    Lakartidningen; 1997 Dec; 94(50):4731-2, 4735-6. PubMed ID: 9445952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives and the risk of DVT.
    Piegsa K; Guillebaud J
    Practitioner; 1996 Sep; 240(1566):544-51. PubMed ID: 8984464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and venous thromboembolism.
    Paul C
    N Z Med J; 1996 Nov; 109(1033):413-5. PubMed ID: 8941290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reporting of adverse drug reactions to the Norwegian Drug Control Agency].
    Skjeldestad FE; Amundsen T; Høibraaten E
    Tidsskr Nor Laegeforen; 2000 Jan; 120(3):336-8. PubMed ID: 10827524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in conceptions before and after the 1995 pill scare.
    Wood R; Botting B; Dunnell K
    Popul Trends; 1997; (89):5-12. PubMed ID: 9368943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H; Norpoth T; Michaels MA
    Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and venous thromboembolism: an epidemiological review.
    Lidegaard O
    Eur J Contracept Reprod Health Care; 1996; 1(1):13-20. PubMed ID: 9678133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.
    Farmer RD; Williams TJ; Simpson EL; Nightingale AL
    BMJ; 2000 Aug 19-26; 321(7259):477-9. PubMed ID: 10948026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral and intrauterine contraception. Use and adverse effects].
    Gram LF; Kovács I; Pedersen A
    Ugeskr Laeger; 1976 May; 138(19):1133-9. PubMed ID: 1265912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Third generation oral contraceptives and risk of venous thrombosis].
    Olsen J
    Ugeskr Laeger; 2002 Jan; 164(3):346. PubMed ID: 11816336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.